Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
---|
CEO | Mr. Pascal Villemagne |
IPO Date | April 22, 2004 |
Location | India |
Headquarters | Dishman Corporate House |
Employees | 1,132 |
Sector | Health Care |
Industries |
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Past 5 years
USD 9.00
USD 26.96
USD 1.89
USD 3.76
USD 14.77
StockViz Staff
January 15, 2025
Any question? Send us an email